Stephen Donnelly (Wicklow, Fianna Fail) | Oireachtas source

My final question is a follow-up. We have been here for hours and it sounds as if an enormous amount of work continues to be done. It also sounds as if it is good, multi-agency work, which we do not always have conversations about in the committee when it comes to healthcare. I wish to ask a question I asked previously again. Mr. Sullivan stated, "The number of medical devices that will have regulatory issues is significant and represents a particular risk to maintaining service continuity from early 2020". He also stated, with regard to medicines, that there remains a potential for delay and disruption to supply routes and that a no-deal Brexit still has the potential to cause disruption to health services. That is fine, but my understanding of what we have been told today is that there are no specific risks at present, the breadth of the work that has been done has looked at all the medicines, the devices and regulation of qualifications and so forth and that the witnesses' position is that, of course, things might happen and we are in a world of unintended consequences and unknown unknowns but they have, therefore, reasonable caveats in their statements. Is it the case, however, that they do not have a shortlist of specific risks where they think things are more likely to go wrong? Essentially, the sense I am getting is that on 1 November things will carry on. They may not, but our guests have nothing left on their plates which says, "However, we think the following two or three disruptions are likely to occur". To ask again a final time, are there specific risks about which they are still concerned, such as specific devices?